Last reviewed · How we verify
NCT07167095: CARE-90
90-Day Mortality After Emergency Department Discharge in Advanced Cancer
trial testing Retrospective Data Collection and Analysis in Advanced Cancer in 1,250 participants. Completed in 1 March 2025.
1 January 2023
Quick facts
| Lead sponsor | Ankara Etlik City Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,250 |
| Start date | 1 December 2022 |
| Primary completion | 1 January 2023 |
| Estimated completion | 1 March 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Retrospective Data Collection and Analysis
Conditions studied
- Advanced Cancer — all drugs for Advanced Cancer →
- Mortality — all drugs for Mortality →
- Oncology — all drugs for Oncology →
- Emergency Department Admission — all drugs for Emergency Department Admission →
Sponsor
Ankara Etlik City Hospital
Who can join
18 and older, any sex, with Advanced Cancer or Mortality. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This retrospective observational study investigates factors associated with 90-day mortality among patients with advanced cancer who present to the emergency department (ED). The study will include stage IV solid tumor patients who visited the ED of Etlik City Hospital between December 2022 and March 2025. Demographic, clinical, and laboratory parameters such as performance status, nutritional and inflammatory markers, and biochemical values will be analyzed. The primary objective is to identify prognostic indicators that predict short-term mortality following ED visits. By establishing risk profiles, the study aims to optimize patient triage, guide timely referral to supportive and palliative care services, and improve overall care strategies for advanced cancer patients in acute settings.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07167095
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Retrospective Data Collection and Analysis
Trials testing the same drug.
- NCT06833723 — Development of a Multi-omics Prediction Model for Immunotherapy Response in Triple-Negative Breast Cancer Subtypes · active not recruiting
Other recruiting trials for Advanced Cancer
Currently open trials in the same condition.
- NCT07393529 — A Pilot Randomized Controlled Trial of a Social Network Intervention · NA · recruiting
- NCT07382544 — Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss · Phase 1 · recruiting
- NCT07246954 — A Chaplain-clinician Led Spiritual Care (PEACE) Intervention on Spiritual/Religious Beliefs Related to Medical Care in P · NA · recruiting
- NCT06346197 — Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas · Phase 3 · recruiting
- NCT07147023 — Better Real-time Information on Documentation of Goals of Care for Engagement in Serious Illness Communication · NA · active not recruiting
Other Ankara Etlik City Hospital trials
Trials by the same sponsor.
- NCT07472452 — MULTIMODAL APPROACH IN THE DIAGNOSIS OF SEPTIC AKI · not yet recruiting
- NCT07488442 — Efficacy of Cognitive Behavioral Therapy Administered in Patients With Dyssynergic Defecation · NA · recruiting
- NCT07488455 — Effectiveness of Video-Based or Written Pelvic Floor Education in Postpartum Women · NA · recruiting
- NCT07375173 — ORI-Guided FiO₂ Titration in Prone Spine Surgery: Impact on Postoperative Atelectasis Assessed by Lung Ultrasound · NA · not yet recruiting
- NCT07456202 — Menstrual Status, Anesthetic Consumption, and PONV · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07167095 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ankara Etlik City Hospital
- Last refreshed: 11 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07167095.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing